106 related articles for article (PubMed ID: 9129871)
1. The clinical value of β-blockers in patients with stable angina.
Palatini P; Faria-Neto JR; Santos RD
Curr Med Res Opin; 2024; 40(sup1):33-41. PubMed ID: 38597064
[TBL] [Abstract][Full Text] [Related]
2. Long term effects of nisoldipine on the progression of coronary atherosclerosis and the occurrence of clinical events: the NICOLE study.
Dens JA; Desmet WJ; Coussement P; De Scheerder IK; Kostopoulos K; Kerdsinchai P; Supanantaroek C; Piessens JH
Heart; 2003 Aug; 89(8):887-92. PubMed ID: 12860866
[TBL] [Abstract][Full Text] [Related]
3. Nisoldipine coat-core. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of ischaemic heart disease.
Langtry HD; Spencer CM
Drugs; 1997 May; 53(5):867-84. PubMed ID: 9129871
[TBL] [Abstract][Full Text] [Related]
4. Antianginal and antiischemic efficacy of monotherapy extended-release nisoldipine (Coat Core) in chronic stable angina.
Glasser SP; Ripa S; Garland WT; Weiss R; Nademanee K; Singh S; Bittar N
J Clin Pharmacol; 1995 Aug; 35(8):780-4. PubMed ID: 8522634
[TBL] [Abstract][Full Text] [Related]
5. Rapid-release and coat-core formulations of nisoldipine in treatment of hypertension, angina, and heart failure.
Hamilton SF; Houle LM; Thadani U
Heart Dis; 1999; 1(5):279-88. PubMed ID: 11720635
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of the controlled-release nisoldipine coat-core tablet formulation.
Heinig R; Ahr G; Hayauchi Y; Kuhlmann J
Int J Clin Pharmacol Ther; 1997 Aug; 35(8):341-51. PubMed ID: 9266290
[TBL] [Abstract][Full Text] [Related]
7. Nisoldipine CC: efficacy and tolerability in hypertension and ischemic heart disease.
Fodor JG
Cardiovasc Drugs Ther; 1997 Jan; 10 Suppl 3():873-9. PubMed ID: 9126676
[TBL] [Abstract][Full Text] [Related]
8. How safe are calcium antagonists in hypertension and coronary heart disease?
Mancia G; van Zwieten PA
J Hypertens; 1996 Jan; 14(1):13-7. PubMed ID: 12013485
[No Abstract] [Full Text] [Related]
9. Pharmacokinetics of Nisoldipine Coat--Core Formulation in Subjects with Liver Cirrhosis.
Shah A; Krol G; Sundaresan P; Lettieri J; Falk R; Lasseter K; Heller AH
Am J Ther; 1995 Jan; 2(1):15-19. PubMed ID: 11850642
[TBL] [Abstract][Full Text] [Related]
10. The calcium channel blocker controversy.
Kaplan NM
Hypertens Res; 1996 Jun; 19(2):57-64. PubMed ID: 10968196
[TBL] [Abstract][Full Text] [Related]
11. Nisoldipine CC: clinical experience in ischaemic heart disease.
Melcher A; Dens J; Curry P; Hagel H
Cardiology; 1997; 88 Suppl 1():17-23; discussion 24-5. PubMed ID: 9118164
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
